Parag Chary

Parag Chary is a Senior Associate Director at Boehringer Ingelheim since May 2022, leading comparative medicine across various therapeutic areas including infectious and non-infectious diseases, as well as vaccines and biotherapeutics. Prior to this role, Parag Chary served as a Senior Principal Scientist at Zoetis from November 2013 to April 2022, where responsibilities included advancing the biopharmaceutical portfolio through innovative technologies. Earlier experience includes positions at Pfizer as a Principal Scientist and Therapeutic Area Head focused on drug discovery, and at IDEXX Laboratories as an Anatomic Pathologist. Parag Chary's academic background includes an Anatomic Pathology Residency from The University of Georgia and multiple post-doctoral fellowships at prestigious institutions. A PhD in Avian Immunopathology was obtained from the University of Minnesota.